These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 15643178

  • 1. Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients.
    Bani-Hani AH, Leibovich BC, Lohse CM, Cheville JC, Zincke H, Blute ML.
    J Urol; 2005 Feb; 173(2):391-4. PubMed ID: 15643178
    [Abstract] [Full Text] [Related]

  • 2. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS, Lohse CM, Zincke H, Cheville JC, Blute ML.
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [Abstract] [Full Text] [Related]

  • 3. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML, Itano NB, Cheville JC, Weaver AL, Lohse CM, Zincke H.
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [Abstract] [Full Text] [Related]

  • 4. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence.
    Blute M, Thibault GP, Leibovich BC, Cheville JC, Lohse CM, Zincke H.
    J Urol; 2003 Sep; 170(3):760-3. PubMed ID: 12913692
    [Abstract] [Full Text] [Related]

  • 5. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, Weaver AL, Parker AS, Zincke H.
    Cancer; 2003 Apr 01; 97(7):1663-71. PubMed ID: 12655523
    [Abstract] [Full Text] [Related]

  • 6. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
    Leibovich BC, Blute M, Cheville JC, Lohse CM, Weaver AL, Zincke H.
    J Urol; 2004 Mar 01; 171(3):1066-70. PubMed ID: 14767272
    [Abstract] [Full Text] [Related]

  • 7. Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience.
    Pahernik S, Roos F, Hampel C, Gillitzer R, Melchior SW, Thüroff JW.
    J Urol; 2006 Jun 01; 175(6):2027-31. PubMed ID: 16697793
    [Abstract] [Full Text] [Related]

  • 8. p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma.
    Shvarts O, Seligson D, Lam J, Shi T, Horvath S, Figlin R, Belldegrun A, Pantuck AJ.
    J Urol; 2005 Mar 01; 173(3):725-8. PubMed ID: 15711252
    [Abstract] [Full Text] [Related]

  • 9. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC, Han KR, Bui MH, Pantuck AJ, Dorey FJ, Figlin RA, Belldegrun A.
    Cancer; 2003 Dec 15; 98(12):2566-75. PubMed ID: 14669275
    [Abstract] [Full Text] [Related]

  • 10. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC, Cheville JC, Lohse CM, Zincke H, Frank I, Kwon ED, Merchan JR, Blute ML.
    J Urol; 2005 Nov 15; 174(5):1759-63; discussion 1763. PubMed ID: 16217278
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
    Carini M, Minervini A, Lapini A, Masieri L, Serni S.
    J Urol; 2006 Jun 15; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
    [Abstract] [Full Text] [Related]

  • 14. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness.
    Sengupta S, Lohse CM, Leibovich BC, Frank I, Thompson RH, Webster WS, Zincke H, Blute ML, Cheville JC, Kwon ED.
    Cancer; 2005 Aug 01; 104(3):511-20. PubMed ID: 15973740
    [Abstract] [Full Text] [Related]

  • 15. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses.
    Gillett MD, Cheville JC, Karnes RJ, Lohse CM, Kwon ED, Leibovich BC, Zincke H, Blute ML.
    J Urol; 2005 Jun 01; 173(6):1893-6. PubMed ID: 15879770
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W, Sanchez-Ortiz R, Tamboli P, Tannir N, Jonasch E, Merchant MM, Matin S, Swanson DA, Wood CG.
    J Urol; 2007 Nov 01; 178(5):1896-900. PubMed ID: 17868729
    [Abstract] [Full Text] [Related]

  • 18. Capsular involvement in patients undergoing partial nephrectomy for localized renal cell carcinoma: an adverse pathological finding?
    Rouach Y, Delongchamps N, Timsit MO, Verkarre V, Fontaine E, Peyromaure M, Mejean A.
    BJU Int; 2010 Mar 01; 105(5):616-9. PubMed ID: 19681891
    [Abstract] [Full Text] [Related]

  • 19. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
    Pahernik S, Cudovic D, Roos F, Melchior SW, Thüroff JW.
    BJU Int; 2007 Jul 01; 100(1):26-9. PubMed ID: 17552949
    [Abstract] [Full Text] [Related]

  • 20. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence.
    Eggener SE, Yossepowitch O, Pettus JA, Snyder ME, Motzer RJ, Russo P.
    J Clin Oncol; 2006 Jul 01; 24(19):3101-6. PubMed ID: 16809736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.